WELCOME to epgonline.org

Access trusted, independent sources of clinical content for the United Kingdom as well as other regions. Registration is quick and simple, providing you with unlimited access to all content and features.

Latest News

Added 2 minutes ago Drug news

EU CHMP recommends Trumenba (Meningococcal Group B Vaccine) immunization of individuals 10 years and older to prevent invasive meningococcal disease . - Pfizer

Pfizer Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...

Added 1 day ago Drug news

FDA approves Symproic (naldemedine) to treat opioid-induced constipation.- Shionogi + Purdue Pharma

Shionogi Inc. and Purdue Pharma L.P. announced that the FDA approved Symproic (naldemedine) 0.2 mg tablets C-II as a once-daily...

Added 1 day ago Drug news

EU Commission approves Amgevita (biosimilar adalimumab) for all indications of the originator drug.- Amgen.

Amgen has announced that the European Commission (EC) has granted marketing authorization for Amgevita (biosimilar adalimumab) in all available indications....

View all news articles


Latest Journal Abstracts

Liraglutide causes large and rapid epicardial fat reduction.

Objective: Epicardial adipose tissue (EAT), the visceral fat depot of the heart, is a modifiable cardiovascular risk factor and emerging therapeutic target. Liraglutide, an analog of glucagon-like peptide-1, is indicated ...

Added 2 days ago

Liraglutide: A Glucagon-Like Peptide-1 Agonist for Chronic Weight Management.

Objective: To review the efficacy and safety of liraglutide 3.0 mg for weight loss.

Added 2 days ago

Selexipag: A Review in Pulmonary Arterial Hypertension.

Selexipag (Uptravi®) is an orally active, first-in-class, selective prostacyclin IP receptor agonist. Selexipag was approved recently in the EU for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients ...

Added 3 days ago

View all journal articles

Latest Guidelines

Japanese Guideline for Adult Asthma 2014

Adult bronchial asthma (hereinafter, asthma) is characterized by chronic airway inflammation, reversible airway narrowing, and airway hyperresponsiveness. Long-standing asthma induces airway remodeling to cause intractable asthma.

Added 2 days ago

Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine.

The development of practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit (ICU) setting for the purpose of guiding clinical practice.

Added 11 days ago

Comfort and patient-centred care without excessive sedation: the eCASH concept.

We propose an integrated and adaptable approach to improve patient care and clinical outcomes through analgesia and light sedation, initiated early during an episode of critical illness and as a priority of care.

Added 11 days ago

View all guidelines